UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041833
Receipt number R000047755
Scientific Title Effect of low-irritant formulation on adherence to growth hormone therapy in pediatric patients with short statue: An exploratory retrospective observational study.
Date of disclosure of the study information 2020/09/18
Last modified on 2021/09/22 12:46:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of low-irritant formulation on adherence to growth hormone therapy in pediatric patients with short statue: An exploratory retrospective observational study.

Acronym

GTL-Adherence

Scientific Title

Effect of low-irritant formulation on adherence to growth hormone therapy in pediatric patients with short statue: An exploratory retrospective observational study.

Scientific Title:Acronym

GTL-Adherence

Region

Japan


Condition

Condition

Short statue caused by growth hormone deficiency, Turner syndrome, or SGA (born small for gestational age)

Classification by specialty

Endocrinology and Metabolism Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

-To retrospectively investigate automatically recorded medication adherence of pediatric patients receiving GH therapy through electronic injector Growjector-L.
-To evaluate effect of low-irritant new formulation of GH (Growject) on medication adherence in comparison with old one.

Basic objectives2

Others

Basic objectives -Others

-To explore factors associated with low adherence to GH therapy.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Medication adherence of patients administered new or old formulation of Growject in daily clinical practice.

Key secondary outcomes

-Patients characteristics.
-Time course change in medication adherence.
-Nonadherence-free survival.
-Exploration on factors affecting adherence to GH therapy.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

3 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

-Treatment-naive at the start of GH therapy.
-Aged 3 years or older at the start of GH therapy.
-Using Growjector-L.
-Started GH therapy between September 1, 2017 and January 31, 2021.
-Written informed consent from a legally acceptable representative of the patient, along with informed assent if applicable.

Key exclusion criteria

-Contraindications for GH therapy.
eg, Diabetes, malignancy, (possible) pregnancy.
-Judgement of physicians.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Kenichi
Middle name
Last name Kashimada

Organization

Tokyo Medical and Dental University

Division name

Department of Pediatrics and Developmental Biology

Zip code

113-8510

Address

1-5-45, Yushima, Bunkyo-ku, 1138510, Tokyo

TEL

03-3813-6111

Email

kkashimada.ped@tmd.ac.jp


Public contact

Name of contact person

1st name Kei
Middle name
Last name Takasawa

Organization

Tokyo Medical and Dental University

Division name

Department of Pediatrics and Developmental Biology

Zip code

113-8510

Address

1-5-45, Yushima, Bunkyo-ku, 1138510, Tokyo

TEL

03-3813-6111

Homepage URL


Email

ktakasawa.ped@tmd.ac.jp


Sponsor or person

Institute

Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

JCR pharmaceuticals Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Life Science and Bioethics Research Center, Tokyo Medical and Dental University

Address

1-5-45, Yushima, Bunkyo-ku, 1138510, Tokyo

Tel

03-3813-6111

Email

info.bec@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科歯科大学医学部附属病院をはじめとする全国約10施設


Other administrative information

Date of disclosure of the study information

2020 Year 09 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

41

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 08 Month 17 Day

Date of IRB

2020 Year 08 Month 17 Day

Anticipated trial start date

2020 Year 09 Month 01 Day

Last follow-up date

2021 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To retrospectively analyze medication adherence data automatically recorded in electronic GH injector Growjector-L.


Management information

Registered date

2020 Year 09 Month 18 Day

Last modified on

2021 Year 09 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047755


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name